ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview

ImageneBio

04/08/2025 21:54

ImageneBio Inc IMA.OQ IMA.O is expected to  show no change in quarterly revenue when it reports  results  for the period ending September 30 2025

​LSEG's mean analyst estimate for ImageneBio Inc is for a loss of $1.56 per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts had risen by about 28.2% in the last three months. ​

Wall Street's median 12-month price target for ImageneBio Inc is $276.00, about 93.7% above its last closing price of $17.28

This summary was machine generated August 4 at 20:54 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)